| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |